Hjem › T-celle-lymfom › Florida
T-celle-lymfom kliniske forsøg i Florida
8 studier for T-celle-lymfom søger deltagere på steder i Florida.
Byer i Florida
Officiel studietekst (engelsk)
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
- UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT04803201Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
- Sylvester Comprehensive Cancer Center University of Miami Miller School of Medicine, Miami
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT06561048Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
- Mayo Clinic in Florida, Jacksonville
- Moffitt Cancer Center-International Plaza, Tampa
- Moffitt Cancer Center - McKinley Campus, Tampa
- og 1 flere
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 14. sep. 2026 · NCT06724237CD4CAR for CD4+ Leukemia and Lymphoma
- University of Miami Sylvester Comprehensive Cancer Center, Miami
RekruttererFase 1
Alder 12 og opefter · Alle køn · Opdateret 24. jun. 2026 · NCT03829540A Phase 1/2 Study of STP938 (Dencatistat) for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas
- Florida Cancer Specialists, Sarasota
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 16. jun. 2026 · NCT05463263A Registry for People With T-cell Lymphoma
- University of Miami (Data Collection Only), Miami
- Moffitt Cancer Center (Data Collection Only), Tampa
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 20. maj 2026 · NCT05978141MB-105 in Patients With CD5 Positive T-cell Lymphoma
- Moffitt Cancer Center Magnolia Campus, Tampa
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 3. okt. 2025 · NCT06534060Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- University of Miami, Miami
RekruttererFase 1
Alder 1 til 21 · Alle køn · Opdateret 6. dec. 2024 · NCT05476770Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.